Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy

NCT01076764 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

13220

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Otamixaban
DRUG: Placebo (for Otamixaban)
DRUG: UFH
DRUG: Placebo (for UFH)
DRUG: Eptifibatide
DRUG: Placebo (for Eptifibatide)

Sponsor

Sanofi